Reed McClung

Reed McClung has extensive experience in the pharmaceutical industry. Reed is currently the Executive Vice President of Oncology Business Development at Eagle Pharmaceuticals, Inc., where they started in July 2022. Prior to that, they held various roles at Bristol-Myers Squibb from 2019 to 2022, including Vice President of US Multiple Myeloma Marketing. From 2017 to 2019, McClung worked at Celgene as the Head of US Multiple Myeloma Marketing and later as the Executive Director of Multiple Myeloma Marketing. Before that, they spent several years at Novartis in various positions, including Sr. Director of Customer Marketing Oncology Managed Markets US and Director of Marketing Excellence. McClung's experience spans across multiple therapeutic areas and they have a strong background in marketing and business development.

Reed McClung attended Mount Allison University from 1986 to 1990, where they pursued a Bachelor's of Science degree in Biology, General.